[Immune defense in hormone-dependent bronchial asthma]

Area of Science:

• Immunology
• Pulmonology
• Pharmacology

Background:

• Hormone-dependent bronchial asthma presents complex clinical and immunological challenges.
• Long-term corticosteroid use is a common treatment but may have significant side effects.

Purpose of the Study:

• To investigate the clinical and immunological effects of long-term corticosteroid therapy in hormone-dependent bronchial asthma.
• To explore alternative therapeutic strategies to mitigate immunosuppression.

Main Methods:

• Clinical assessment of patients with hormone-dependent bronchial asthma.
• Immunological profiling, including lymphocytic subpopulations and opsonophagocytosis.
• Evaluation of alternative treatments like immunomodulators and extracorporeal techniques.

Main Results:

• Long-term corticosteroid therapy demonstrated a significant immunosuppressive effect on lymphocytic subpopulations and opsonophagocytosis.
• Immunological deficits correlated with reduced anti-infective defense.
• These deficits contribute to a more severe asthma course, particularly with chronic obstructive bronchitis.

Conclusions:

• Long-term corticosteroid therapy adversely impacts immune function in hormone-dependent asthma.
• Reduced immune defense increases susceptibility to infections and disease exacerbation.
• Immunomodulators and extracorporeal techniques represent viable alternatives to escalating corticosteroid dosages, mitigating immunosuppressive effects.